CeCors, Inc. engages in the acquisition and development of healthcare companies focusing on military veterans. The company is headquartered in Sarnia, Ontario and currently employs 6 full-time employees. The company went IPO on 2005-11-02. PsyKey Inc. understands the importance of access to support services and healthcare professionals and is continuously engaged in the development of tools that will aid in removing barriers and providing inclusivity. PsyKey Inc. is also engaged in the scientific development of patentable technologies pertaining to the composition, bioavailability and targeted delivery of entheogen-based therapeutics. The company produces functional mushroom-based products. Its products consist of infused coffee blends and capsule supplements. Its subsidiary is VETCOMM, is a provider of Veterans Affairs benefits courses and services and offers ad hoc claims support services.
How did CEOS's recent EPS compare to expectations?
The most recent EPS for CeCors Inc is $, expectations of $.
How did CeCors Inc CEOS's revenue perform in the last quarter?
CeCors Inc revenue for the last quarter is $
What is the revenue estimate for CeCors Inc?
According to of Wall street analyst, the revenue estimate of CeCors Inc range from $ to $
What's the earning quality score for CeCors Inc?
CeCors Inc has a earning quality score of A-/59.288963. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does CeCors Inc report earnings?
CeCors Inc next earnings report is expected in 2026-01-04
What are CeCors Inc's expected earnings?
CeCors Inc expected earnings is $, according to wall-street analysts.